Letter to the editor: Comment on “possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial”
Crossref DOI link: https://doi.org/10.1007/s12032-024-02502-6
Published Online: 2024-10-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Jiaan
Zhuang, Ziye
Chi, Hao
Text and Data Mining valid from 2024-10-14
Version of Record valid from 2024-10-14
Article History
Received: 5 September 2024
Accepted: 13 September 2024
First Online: 14 October 2024
Declarations
:
: The authors declare no competing interests.